THE EFFECT OF BISOPROLOL ON DISEASE COURSE FOR PATIENTS WITH HIGH SST2 LEVELS AND ACUTE  MYOCARDIAL  INFARCTION

N. P. Kopytsya; Ya. V. Hilova; A.V. Kobets

doi:10.29256/v.02.02.2018.escbm20

N. P. Kopytsya Government institution «L.T.Malaya Therapy National Institute of the National Academy of Medical Science of Ukraine», Ukraine
Ya. V. Hilova Government institution «L.T.Malaya Therapy National Institute of the National Academy of Medical Science of Ukraine», Ukraine
A.V. Kobets Government institution «L.T.Malaya Therapy National Institute of the National Academy of Medical Science of Ukraine», Ukraine

DOI: https://doi.org/10.29256/v.02.02.2018.escbm20

Keywords: sST2, аcute myocardial infarction, beta-blockers, bisoprolol

Abstract

THE EFFECT OF BISOPROLOL ON DISEASE COURSE FOR PATIENTS WITH HIGH SST2 LEVELS AND ACUTE MYOCARDIAL INFARCTION

References

1. Januzzi J L., Pascual-FigalD, DanielsLB. ST2 Testing for Chronic Heart Failure Therapy Monitoring: The International ST2 Consensus Panel. Journal of the American College of Cardiology. 2015; 115 (7Suppl):70B-5B.

2. López-SendónJ, SwedbergK, McMurrayJ, etal. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J.2004; 25:1341.

3. Miller A.M. Role of IL-33 in inflammation and disease. J. Inflamm. (Lond).2011; 8 (1): 22-26.

4. Mueller T., Dieplinger B., A. Gegenhuber et al. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure. Clin. Chem. 2008; 54: 752-756.

5. Weinberg E.O., Shimpo M., Hurwitz S. et al. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation. 2003; 107: 721-726.